Market Place
Sourcing Support
Altasciences Strengthens Commitment to Pharma & Biotech Services
13 Nov 2024 //
BUSINESSWIRE
Altasciences` CSO Named PharmaVoice 100 Honoree
09 Oct 2024 //
BUSINESSWIRE
Altasciences Receives 2024 CRO Leadership Award for Capabilities
29 May 2024 //
BUSINESSWIRE
Flipping the drug development industry on its head
05 Apr 2024 //
REUTERS
Hoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT
26 Feb 2024 //
PR NEWSWIRE
Altasciences Appoints New General Manager, Clinical Operations
29 Jan 2024 //
BUSINESSWIRE
Altasciences ernennt neuen General Manager, Clinical Operations
29 Jan 2024 //
BUSINESSWIRE
Altasciences Completes Expansion of New State-Of-The-Art Laboratory in Columbia
31 Oct 2023 //
BUSINESSWIRE
Angel Reyes Joins Altasciences as General Manager of CDMO Services
06 Oct 2023 //
BUSINESSWIRE
Altasciences Chosen by Virpax to Support the Development of Flu-like Viruses
21 Sep 2023 //
BUSINESSWIRE
Altasciences Receives 2023 CRO Leadership Award for Capabilities
09 May 2023 //
BUSINESSWIRE
Altasciences Completes Clinical Portion of Alzamend Neuro’s Phase IIa Trial
14 Apr 2023 //
CONTRACT PHARMA
Altasciences Chooses Proscia’s Digital Pathology Platform
21 Mar 2023 //
CONTRACT PHARMA
Altasciences Expands Laboratory Capabilities in Columbia
14 Feb 2023 //
BUSINESSWIRE
Altasciences Expands Support, Preclinical Staff
10 Feb 2023 //
CONTRACT PHARMA
Altasciences Expands Strategic Support in Europe and Adds Key Employees
09 Feb 2023 //
BUSINESSWIRE
Altasciences Los Angeles Clinical Site Receives CAP Accreditation
01 Nov 2022 //
CONTRACTPHARMA
Altasciences Expands Laboratory Capabilities in Columbia
19 Oct 2022 //
BUSINESSWIRE
Altasciences Expands Strategic Support for Early Drug Development in Europe
14 Oct 2022 //
BUSINESSWIRE
Sharp Adds New Talent with Clinical Leadership Appointments
11 Oct 2022 //
PRESS RELEASE
Hoth Announces Partnership with Altasciences for Manufacturing HT-TBI
20 Sep 2022 //
PRNEWSWIRE
Altasciences kicks off client manufacturing expansion in Philadelphia
15 Jul 2022 //
ENDPTS
Altasciences Receives CRO Leadership Award in Five Categories
30 May 2022 //
BUSINESSWIRE
Dr. Wendell P. Davis Joins Altasciences as Vice President, Pathology
07 Feb 2022 //
BUSINESSWIRE
Altasciences Chosen by Virpax Pharma to Conduct Study of Epoladerm
21 Jan 2022 //
BUSINESSWIRE
Altasciences Acquires Sinclair Research & Continues to Expand PC Platform
04 Jan 2022 //
BUSINESSWIRE
Virpax Announces Clinical Trial Site for First in Human Study of Epoladerm
20 Dec 2021 //
BUSINESSWIRE
Altasciences Chosen by Respira as Drug Product Manufacturing Partner for NRT
14 Dec 2021 //
BUSINESSWIRE
XORTX Selects Altasciences to Conduct Pharmacokinetic Bridging Study
09 Dec 2021 //
CONTRACTPHARMA
Altasciences Chosen by XORTX to Conduct Pharmacokinetic Study of XRX-OXY-101
09 Dec 2021 //
BUSINESSWIRE
Altasciences Expands Ligand Binding Laboratory
23 Nov 2021 //
BUSINESSWIRE
Altasciences continues to expand its premises with a new site in Philadelphia
27 Sep 2021 //
BUSINESSWIRE
Altasciences Continues Expansion with Additional Facilities in Philadelphia
27 Sep 2021 //
CONTRACTPHARMA
Alzamend Neuro and Altasciences to conduct a Phase I study for AL001.
17 Aug 2021 //
BUSINESSWIRE
Altasciences Appoints Dr. Bruce Frank as VP, CDMO Operations
17 Aug 2021 //
CONTRACT PHARMA
Bruce Frank joins Altasciences as Vice President, CDMO Operations
13 Aug 2021 //
BUSINESSWIRE
Altasciences Initiates Phase I Study in Healthy Normal Subjects for ST-2427
13 May 2021 //
BUSINESSWIRE
Altasciences Initiates Phase I Study in Healthy Normal Subjects for ST-2427
13 May 2021 //
BUSINESSWIRE
Altasciences Conducts Preclinical Studies in Support of Verve Therapeutics
12 Mar 2021 //
BUSINESSWIRE
Altasciences Doubles Size of PA CDMO Facility
10 Mar 2021 //
CONTRACTPHARMA
Altasciences Conducts Phase I Study in Healthy Normal Subjects for RLS-0071
03 Mar 2021 //
BUSINESSWIRE
Altasciences Conducts Phase I Study in Healthy Normal Subjects for RLS-0071
03 Mar 2021 //
BUSINESSWIRE
Altasciences führt Phase-I-Studie zu RLS-0071 bei akuter Lungenschädigung durch
03 Mar 2021 //
BUSINESSWIRE
Altasciences Contributes to Vibegron Approval
24 Feb 2021 //
CONTRACTPHARMA
Altasciences Performs Phase I Studies for FDA Approval of Vibegron
23 Feb 2021 //
BUSINATSSWIRE
Novo Holdings to acquire Altasciences
22 Feb 2021 //
PRNEWSWIRE
Altasciences completes acquisition of US-based CRO WCCT Global
19 Feb 2021 //
CLINICALTRIALSARENA
ALTASCIENCES COMPLETES PHASE I STUDY ON GIMSILUMAB FOR ARDS IN COVID-19
28 Mar 2020 //
ALTASCIENCES
Altasciences Completes Phase I Study in COVID-19 Patients
27 Mar 2020 //
CONTRACT PHARMA
Altasciences Completes Phase I Study on Gimsilumab for ARDS in COVID-19
27 Mar 2020 //
GLOBENEWSWIRE
Altasciences Appoints Senior Director Compliance and RA
10 Jan 2020 //
CONTRACT PHARMA
Immuneering Strengthens Executive Team With Appointment of Howard L.
09 Jan 2020 //
GLOBE NEWSWIRE
Altasciences to Conduct Clinical Trial for Opioid Use Disorder Under NIH Funding "
13 Dec 2019 //
BUSINESSWIRE
CRO Altasciences nabs ex-Charles River executive
05 Sep 2019 //
FIERCE BIOTECH
Altasciences Leads Research on Chemical Nerve Agent from Preclinical to ph1
22 May 2019 //
BUSINESSWIRE
Altasciences Announces Launch of New Brand and Website
12 Feb 2019 //
BUSINESSWIRE
